Codexis Past Earnings Performance

Past criteria checks 0/6

Codexis's earnings have been declining at an average annual rate of -37.7%, while the Life Sciences industry saw earnings growing at 13.9% annually. Revenues have been growing at an average rate of 3.5% per year.

Key information

-37.7%

Earnings growth rate

-34.1%

EPS growth rate

Life Sciences Industry Growth26.8%
Revenue growth rate3.5%
Return on equity-84.6%
Net Margin-96.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Codexis makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:4QK Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2464-62540
30 Jun 2461-76530
31 Mar 2474-65510
31 Dec 2370-76530
30 Sep 2374-82530
30 Jun 2399-57550
31 Mar 23116-48520
31 Dec 22139-34520
30 Sep 22133-31520
30 Jun 22135-19510
31 Mar 22122-21540
31 Dec 21105-21490
30 Sep 21101-15460
30 Jun 2183-23420
31 Mar 2172-25370
31 Dec 2069-24350
30 Sep 2067-21340
30 Jun 2070-14330
31 Mar 2068-14320
31 Dec 1968-12320
30 Sep 1966-12310
30 Jun 1961-14300
31 Mar 1962-11300
31 Dec 1861-11290
30 Sep 1866-9300
30 Jun 1859-18310
31 Mar 1856-20300
31 Dec 1750-23290
30 Sep 1738-29280
30 Jun 1743-18250
31 Mar 1749-9250
31 Dec 1649-9250
30 Sep 1650-5240
30 Jun 1653-1250
31 Mar 1643-9240
31 Dec 1542-8220
30 Sep 1544-5210
30 Jun 1534-15210
31 Mar 1535-18210
31 Dec 1435-19220
30 Sep 1431-29220
30 Jun 1427-34230
31 Mar 1428-38250
31 Dec 1332-41270

Quality Earnings: 4QK is currently unprofitable.

Growing Profit Margin: 4QK is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 4QK is unprofitable, and losses have increased over the past 5 years at a rate of 37.7% per year.

Accelerating Growth: Unable to compare 4QK's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 4QK is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-1.4%).


Return on Equity

High ROE: 4QK has a negative Return on Equity (-84.59%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 06:34
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Codexis, Inc. is covered by 20 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
J. HorwitzBaird
Vishal ShahBarclays
Robert WassermanBenchmark Company